A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : SAS / sympathoadrenal system

[Related PubMed/MEDLINE]
Total Number of Papers: 55
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   SAS  (>> Co-occurring Abbreviation)
Long Form:   sympathoadrenal system
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2016 [State of adaptive systems of the body in boys aged of 11-15 years in the process of their age development, pubertal maturation and in the dynamics of the school year]. 17-KS, 17-OKS, AC, NA
2014 Corticotropin-releasing hormone and the sympathoadrenal system are major mediators in the effects of peripherally administered exendin-4 on the hypothalamic-pituitary-adrenal axis of male rats. Ex-4, GLP-1, HPA
2014 Deafferentation of the hypothalamic paraventricular nucleus (PVN) exaggerates the sympathoadrenal system activity in stressed rats. CORT, EPI, HPA, IMO, NE, PVN, PVN, SHAM
2014 [Role of the change of daily rhythms of adrenaline and noradrenaline concentration in blood in the mechanism of accelerated aging in hypopinealizm induced by a long period of day and night lighting]. ---
2013 Neuroendocrine homeostasis after vagus nerve stimulation in rats. Fos-IR, VNP, VNS
2012 Medial prefrontal cortex transection enhanced stress-induced activation of sympathoadrenal system in rats. CS, HPA, IMO, mPFC
2012 The immune response to surgery and trauma: Implications for treatment. Arg1, CARS, CMI, HPA, IL-12, IMDs, MDSC's, SIRS, Th2
2011 Eugenol as an anti-stress agent: modulation of hypothalamic-pituitary-adrenal axis and brain monoaminergic systems in a rat model of stress. BMS, HPA, NE
2011 Perinatal nutritional programming of health and metabolic adult disease. HPA
10  2009 Acute incremental exercise, performance of a central executive task, and sympathoadrenal system and hypothalamic-pituitary-adrenal axis activity. ACTH, HPAA, MAP, RT
11  2009 Disrupted serotonergic and sympathoadrenal systems in patients with chronic heart failure may serve as new therapeutic targets and novel biomarkers to assess severity, progression and response to treatment. CHF, DD, SS
12  2009 [Neurohumoral regulation of blood pressure in rheumatic patients]. AH, BP, HV, RAAS, SLE, SS
13  2008 [Clinical efficacy of antihypertensive therapy of pregnant women with arterial hypertension with long acting nifedipine and bisoprolol]. HD
14  2007 Neurohumoral changes in chronic heart failure. CHF, RAAS, TNF
15  2007 [A new approach to the rating of psychological disadaptation in extreme conditions]. ---
16  2006 Effect of lesion of a5 and a7 brainstem noradrenergic areas or transection of brainstem pathways on sympathoadrenal activity in rats during immobilization stress. ---
17  2005 Stimulating effect of adaptogens: an overview with particular reference to their efficacy following single dose administration. HPA
18  2005 [Primary pulmonary hypertension: activation of sympathico-adrenal system and free radical oxidation. Positive effects of carvedilol therapy]. HRV, PPH
19  2004 Catecholamine synthesizing enzymes and their modulation by immobilization stress in knockout mice. c-fos KO, CRH KO, DBH, HPA, PNMT, RT-PCR, TH, WT
20  2002 Diagnosis of stress. HPA
21  2002 Stress: a risk factor for serious illness. HPA, PTSD
22  2002 [Adrenoreactivity as a criterion for the evaluation of some professionally important qualities of the human operator]. PPS
23  2001 Effect of microgravity on plasma catecholamine responses to stressors during space flight. CA
24  2000 Adrenomedullary function and its regulation in obesity. AM, SNS
25  1999 [The effect of neurohumoral factors of the sympathoadrenal system on the results of cataract extraction with intraocular lens implantation in diabetic patients]. ---
26  1999 [The functional status of the sympathoadrenal system in hypertension patients being treated with captopril and dalargin]. CA, EDE, HD
27  1998 [The function of the cholinergic and sympathoadrenal systems in miners with long-term exposure to manganese oxides]. ChS, MO
28  1997 [Sympathoadrenal activity during the treatment of patients with cancer of the stomach and large intestine]. ---
29  1996 [New approaches in the evaluation of sympathoadrenal system activity during periods of rest and stress]. CA, DHPG, DOPA, DOPAC, HVA, IMO, MHPG, NA, NMN
30  1995 Metabolic and hormone-related responses to caffeine in rats. NEFA
31  1995 [An experimental study of the effect of an artichoke preparation on the activity of the sympathetic-adrenal system in carbon disulfide exposure]. ---
32  1994 New approaches to evaluate sympathoadrenal system activity in experiments on earth and in space. ADR, CA, DA, DHPG, DOPA, DOPAC, HVA, IMO, MHPG, NE
33  1993 Sleep disorders and anxiety as symptom profiles of sympathoadrenal system hyperactivity in major depression. CA, DA, HDRS, MHPG, NE, SCID
34  1993 [The administration of corticoliberin into the caudate nucleus activates the sympathetic-adrenal medullary and hypophyseal-adrenal cortical systems by different mechanisms]. ---
35  1991 [Changes in the sympathetic-adrenal system during stress in rats with high and low resistance to acute hypoxia]. AM, CL, HRH, NE, RAFAT, SSCV
36  1991 [Characteristics of immunologic and neuro-hormonal status in patients with neuroses]. ---
37  1991 [The concentrations of somatotropic hormone and insulin in the blood of heart surgery patients with a complicated course of the postoperative period]. HAS, STH
38  1989 [Activity of the sympathetico-adrenal system in humans during modeling of weightlessness]. DA, NA
39  1989 [Interrelations between blood circulation and the activity of the sympathetic-adrenal system in infants with acute pneumonia and its suppurative complications]. ---
40  1989 [The course of the early postoperative period in heart surgery patients in relation to the state of humoral regulatory mechanisms]. ---
41  1989 [The sympathetic-adrenal system during reflex analgesia used in the treatment of a pathological preliminary period]. ---
42  1988 [Reflexotherapy of asthenic conditions in neuroses]. ---
43  1988 [The L-DOPA test in patients with obsessive fear neurosis]. ---
44  1987 Glucose, insulin and sympathoadrenal activation. NE, SNS
45  1987 [Functional state of the sympatho-adrenal system at late stages of the tumor process after cyclophosphamide and 5-fluorouracil administration]. ---
46  1986 [Reactivity of the sympathetic-adrenal system and physical loading tolerance in multiple exposures to a permanent magnetic field]. ---
47  1985 [Catecholamine metabolism in a high-altitude environment]. ---
48  1985 [Reaction of the sympathetic-adrenal system of patients with tumors of the sellar-diencephalic region in the postoperative period]. ---
49  1984 [Effect of obzidan on the indices of gas exchange and the sympathetic-adrenal system in ischemic heart disease patients with different types of circulation]. CHD, MOC
50  1984 [Electrophysiological and catecholamine mechanisms of negative feedback in regulation of the hypothalamus by male sex glands]. HPGS
51  1983 [Circadian rhythm of catecholamine excretion, effect of L-DOPA and Nacom in various diseases of the nervous system]. CA, DA, DMD
52  1982 [Results of endocrinologic studies of the 3d international crew of the scientific orbital station complex: Soyuz 29--Salyut 6--Soyuz 31 (joint space flight enterprise of the USSR--GDR). 1. Condition of the sympathico-adrenal system]. CA, DA, HVA, MN, NA, NA, NMN, VMA
53  1981 [Human sympathetic-adrenal system during water immersion]. ---
54  1980 [Correlations between the indices of the state of the sympathetic-adrenal and of the hypophyseal-adrenal systems and the level of insulin in horses under various exposures]. HAS
55  1980 [Role of hypothalamic monoaminergic structures in regulating sympatho-adrenal system function]. ---